- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT01375530
Screening van vrijwilligers voor klinische onderzoeken
VRC 500: Vrijwilligers screenen voor klinische proeven van onderzoeksproducten en gelicentieerde producten geëvalueerd voor onderzoeksdoeleinden
Background:
- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices. The VRC conducts studies that will allow researchers to better understand the immune system and how vaccines and monoclonal antibodies work.
Objectives:
- To screen healthy volunteers for clinical trials at the NIAID VRC.
Eligibility:
- Healthy people between 18 and 60 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies.
Design:
- Screening for healthy volunteers to participate in clinical trials is an ongoing process.
- Volunteers will be asked about their medical history, including sexual activity and drug use, and a detailed physical exam will be performed.
- Blood and urine samples may be collected, and possibly other tests as needed to evaluate the volunteer's health status.
- Volunteers will not receive any investigational product in this screening protocol.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
The purpose of this study is to recruit and screen potential study subjects, mostly healthy volunteers, to determine if they are eligible for clinical trials of investigational products. This screening study also aims to characterize and analyze demographic information as well as laboratory and other medical findings in terms of how they may affect the eligibility of subjects for specific early phase clinical trials. All work will be conducted by the VRC Clinic of the National Institutes of Health or other IRB-approved sites that are collaborating with NIAID/VRC. Educational and recruitment materials on the investigational products and protocols will be
reviewed with and provided to subjects during participation in the screening protocol.
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: VRC Recruitment
- Telefoonnummer: (866) 833-5433
- E-mail: vrcrecruitment@mail.nih.gov
Studie Locaties
-
-
Georgia
-
Atlanta, Georgia, Verenigde Staten, 30030
- Voltooid
- Emory University
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21201-1595
- Actief, niet wervend
- Univ of MD School of Medicine Center for Vaccine Development & Global Health
-
Bethesda, Maryland, Verenigde Staten, 20892
- Werving
- National Institutes of Health Clinical Center
-
Contact:
- VRC Clinic
- Telefoonnummer: 301-451-8715
- E-mail: vaccines@nih.gov
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19104-6056
- Voltooid
- University of Pennsylvania-UPenn
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Healthy volunteers
Beschrijving
- INCLUSION CRITERIA:
Age: 18 years of age or older
Able and willing to complete the informed consent process
Agree to have blood and/or tissue samples collected and stored for future studies of investigational products, the immune system, and/or other medical conditions
EXCLUSION CRITERIA:
A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access
A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being
Known to be pregnant or breast-feeding
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: OTHER
- Tijdsperspectieven: OTHER
Cohorten en interventies
Groep / Cohort |
|---|
|
1
Healthy adults 18 - 60 years old |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
To screen subjects for their eligibility to participate in clinical trials.
Tijdsspanne: Ongoing
|
Duration of subject participation is variable, and may last from a few weeks to several months for each subject. |
Ongoing
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Lasonji A Holman, C.R.N.P., National Institute of Allergy and Infectious Diseases (NIAID)
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Geschat)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 110164
- 11-I-0164
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .